Fugui Yan

451 total citations
21 papers, 266 citations indexed

About

Fugui Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Fugui Yan has authored 21 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Infectious Diseases. Recurrent topics in Fugui Yan's work include Antifungal resistance and susceptibility (3 papers), interferon and immune responses (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Fugui Yan is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), interferon and immune responses (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Fugui Yan collaborates with scholars based in China, United States and Germany. Fugui Yan's co-authors include Huahao Shen, Wen Li, Jiandong Li, Yinfang Wu, Hirofumi Jono, Zhihua Chen, Yanping Wu, Qingmei Li, Shuangmei Zhang and Wen Li and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Fugui Yan

18 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fugui Yan China 10 108 90 73 45 43 21 266
Boška Hrvačić Croatia 9 53 0.5× 65 0.7× 83 1.1× 33 0.7× 61 1.4× 20 271
Matthias Hagner Germany 9 81 0.8× 93 1.0× 154 2.1× 18 0.4× 50 1.2× 13 341
Kristie L. Hilliard United States 9 88 0.8× 154 1.7× 70 1.0× 51 1.1× 16 0.4× 9 333
Arpan Sharma Neupane United States 7 121 1.1× 181 2.0× 93 1.3× 30 0.7× 14 0.3× 8 381
François Carlier Belgium 9 81 0.8× 71 0.8× 193 2.6× 23 0.5× 81 1.9× 22 348
Lani San Mateo United States 7 100 0.9× 166 1.8× 50 0.7× 42 0.9× 38 0.9× 12 308
Sangeetha Jayaraman United States 7 157 1.5× 90 1.0× 22 0.3× 56 1.2× 30 0.7× 12 320
William J. Branchett United Kingdom 9 64 0.6× 166 1.8× 66 0.9× 68 1.5× 79 1.8× 12 358
Ruvalic M. Buijs‐Offerman Netherlands 8 140 1.3× 33 0.4× 205 2.8× 25 0.6× 30 0.7× 8 377
Giuseppe Paolicelli Italy 7 58 0.5× 86 1.0× 34 0.5× 37 0.8× 47 1.1× 9 205

Countries citing papers authored by Fugui Yan

Since Specialization
Citations

This map shows the geographic impact of Fugui Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fugui Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fugui Yan more than expected).

Fields of papers citing papers by Fugui Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fugui Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fugui Yan. The network helps show where Fugui Yan may publish in the future.

Co-authorship network of co-authors of Fugui Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Fugui Yan. A scholar is included among the top collaborators of Fugui Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fugui Yan. Fugui Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Jiang, Li, et al.. (2025). Herniarin Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Regulating Oxidative Stress, Inflammation and Apoptosis Mechanisms. Indian Journal of Pharmaceutical Education and Research. 59(4). 1375–1384.
4.
Yan, Fugui, et al.. (2024). Computer-assisted discovery and evaluation of potential ribosomal protein S6 kinase beta 2 inhibitors. Computers in Biology and Medicine. 172. 108204–108204. 1 indexed citations
5.
Chen, Zhu, et al.. (2024). Enhancing knowledge mastery in resident students through peer-teaching: a study in respiratory medicine. BMC Medical Education. 24(1). 350–350.
6.
Shao, Zhehua, Shiyi Yang, Yinfang Wu, et al.. (2023). Airway epithelial cGAS inhibits LPS-induced acute lung injury through CREB signaling. Cell Death and Disease. 14(12). 844–844. 5 indexed citations
8.
Yan, Fugui, Huaqiong Huang, Hua Wen, et al.. (2023). [Review and perspective of clinical research involving chest tightness variant asthma in China].. PubMed. 103(34). 2639–2646.
9.
Xia, Yang, Songmin Ying, Rui Jin, et al.. (2021). Application of a classifier combining bronchial transcriptomics and chest computed tomography features facilitates the diagnostic evaluation of lung cancer in smokers and nonsmokers. International Journal of Cancer. 149(6). 1290–1301. 5 indexed citations
10.
Xia, Yang, Jianping Zhao, Lihua Wang, et al.. (2021). A rapid screening classifier for diagnosing COVID-19. International Journal of Biological Sciences. 17(2). 539–548. 16 indexed citations
11.
Zhang, Hao, Fen Lan, Huaqiong Huang, et al.. (2020). Detection of Viruses by Multiplex Real-Time Polymerase Chain Reaction in Bronchoalveolar Lavage Fluid of Patients with Nonresponding Community-Acquired Pneumonia. Canadian Respiratory Journal. 2020. 1–7. 5 indexed citations
12.
Chen, Lin, Yinfang Wu, Yanping Wu, et al.. (2020). Airway Epithelial cGAS Is Critical for Induction of Experimental Allergic Airway Inflammation. The Journal of Immunology. 204(6). 1437–1447. 46 indexed citations
13.
Yan, Fugui, Yinfang Wu, Huiwen Liu, et al.. (2018). ATF3 is positively involved in particulate matter-induced airway inflammation in vitro and in vivo. Toxicology Letters. 287. 113–121. 15 indexed citations
14.
Lin, Xiaoping, Hongbin Zhou, Yinfang Wu, et al.. (2014). Nuclear erythroid 2 p45-related factor–2 Nrf2 ameliorates cigarette smoking-induced mucus overproduction in airway epithelium and mouse lungs. Microbes and Infection. 16(10). 855–863. 6 indexed citations
15.
Yan, Fugui, Wen Li, Hongbin Zhou, et al.. (2014). Interleukin-13-induced MUC5AC expression is regulated by a PI3K–NFAT3 pathway in mouse tracheal epithelial cells. Biochemical and Biophysical Research Communications. 446(1). 49–53. 15 indexed citations
16.
Li, Wen, Fugui Yan, Hongbin Zhou, et al.. (2013). P. aeruginosa Lipopolysaccharide-Induced MUC5AC and CLCA3 Expression Is Partly through Duox1 In Vitro and In Vivo. PLoS ONE. 8(5). e63945–e63945. 27 indexed citations
17.
Li, Wen, Fen Lan, Fugui Yan, & Huahao Shen. (2012). Angiotensin-converting Enzyme I/D Polymorphism is Associated with COPD Risk in Asian Population: Evidence from a Meta-analysis. COPD Journal of Chronic Obstructive Pulmonary Disease. 10(1). 35–39. 10 indexed citations
18.
Yan, Fugui, Chengshui Chen, Jiyong Jing, et al.. (2010). Association between polymorphism of glutathione S-transferase P1 and chronic obstructive pulmonary disease: A meta-analysis. Respiratory Medicine. 104(4). 473–480. 15 indexed citations
19.
Shen, Huahao, Hiroki Yoshida, Fugui Yan, et al.. (2007). Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumoniae. Biochemical and Biophysical Research Communications. 365(4). 795–800. 27 indexed citations
20.
Yan, Fugui, Wen Li, Hirofumi Jono, et al.. (2007). Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-α signaling pathways in human airway epithelial cells. Biochemical and Biophysical Research Communications. 366(2). 513–519. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026